Hybridization of single-stranded RNA from virions of human enteroviruses with denatured double-stranded RNA from infected cells indicates that a minimum of about 5% of the genome is shared by these viruses. Polynucleotide sequence relationships, furthermore, are consistent with the biologic classification into polioviruses, coxsackieviruses groups A and B, and echoviruses. In general, about 30 to 50% of the nucleotide sequences are shared by different serotypes of virus within each of these major groups, whereas among different groups less than 20% homology is observed. Coxsackievirus B4 appears to be more closely related to echoviruses than to group A coxsackieviruses, whereas polioviruses are only distantly related to any of the other agents.
Hybridization of single-stranded RNA from virions of human enteroviruses with denatured double-stranded RNA from infected cells indicates that a minimum of about 5% of the genome is shared by these viruses. Polynucleotide sequence relationships, furthermore, are consistent with the biologic classification into polioviruses, coxsackieviruses groups A and B, and echoviruses. In general, about 30 to 50% of the nucleotide sequences are shared by different serotypes of virus within each of these major groups, whereas among different groups less than 20% homology is observed. Coxsackievirus B4 appears to be more closely related to echoviruses than to group A coxsackieviruses, whereas polioviruses are only distantly related to any of the other agents.
More than 65 serotypes of human enteroviruses are currently recognized (7) . These acid-stable picornaviruses have virion diameters of 18 to 25 nm, buoyant densities in CsCl of 1.32 to 1.35 g/cm3 (5) , and are protected by divalent cations against thermal inactivation (11) .
Human enteroviruses have been further subclassified into three taxa-polioviruses, coxsackieviruses, and echoviruses-based on biologic and antigenic relationships. Polioviruses are pathogenic for the central nervous system of primates and primate cell cultures, whereas coxsackieviruses were initially distinguished from polioviruses by producing paralysis in suckling mice but no cytopathic effect in cultured cells (4) . Moreover, group B coxsackieviruses produce different clinical syndromes and a different type of histopathologic lesion in mice than group A coxsackieviruses and frequently replicate in cell cultures. Echoviruses are characterized by the production of cytopathic effects in cultured cells but failure to cause lesions in laboratory animals. Within each of these three groups, distinct serotypes are recognized by neutralization tests. However, the existence of common antigens is indicated by minor cross-reactivity, especially by complement fixation tests, among individual serotypes of coxsackieviruses as well as between coxsackieviruses and echoviruses (9) .
Problems have arisen from this biological classification because newly discovered strains antigenically like coxsackieviruses are cytopathic for cell cultures without paralyzing mice, whereas other strains are pathogenic for mice but are antigenically related to echoviruses. These difficulties have led to a taxonomic scheme in which newly recognized enteroviruses are given serial numbers beginning with enterovirus 68 rather than being classified as coxsackieviruses or echoviruses (7) .
An independent means of categorizing enteroviruses, especially one capable of establishing quantitative as well as qualitative relationships, could be expected to shed light on the basic validity of the biologic classification. It was previously demonstrated by RNA-RNA hybridization that about 26 to 38% of the genome is common to the three antigenic types of polioviruses (14) . These studies are now extended to representative strains of coxsackieviruses and echoviruses with a view to elucidating their interrelationships.
MATERIALS AND METHODS
Viruses and immune sera. The virus strains and their sources are listed in Table 1 . The complete pedigree of most of these extensively passaged strains is unknown. Immune sera were obtained from the Research Resources Branch, National Institute of Allergy and Infectious Diseases. Propagation of viruses. Preliminary experiments indicated that all strains studied except coxsackievirus A10 produced infectivity titers of at least 107.0 to 107 ' PFU per ml in cultures of Vero cells. Accordingly, these cells were cultivated in roller bottles, approximate surface area 1,410 cm2 (Bellco Glass Inc.), in medium 199 with 5% fetal calf serum. Confluent monolayers were washed with Hanks balanced salt solution and then infected at a multiplicity of 10 to 30 PFU/cell. After adsorption for 30 min at 37 C, the inoculum was replaced by 50 ml of medium 199 lacking serum and incubated until yields of infectious virus were maximal as determined by preliminary experiments, usually at 5 to 7 h after infection.
For the production of coxsackievirus A10, 60 litters of 2-day-old white mice (NIH all purpose) were inoculated intraperitoneally with 104-5 mean lethal doses, and the carcasses were harvested when the animals were moribund by decapitating and eviscerating them.
Infectivity assays and neutralization tests. These assays were performed as previously described (14) except for the addition of 25 mmol of MgCl2 to the agar overlay (12) .
Purification of viruses. The method of purifying poliovirus after elution of virus from diethylaminoethyl (DEAE) cellulose (Whatman DE 23) columns has been described (14) . This method was also used to purify coxsackievirus A7 and echovirus 1. A small amount of 32P-labeled virus was first prepared by infecting 2 x 107 to 6 x 107 cells with virus in the presence of actinomycin D, 1 gg/ml, and 50 uCi of 32P-orthophosphate per ml from 0 to 6 h postinfection. After freeze-thawing the cells three times and removing cellular debris by centrifugation at 2,000 x g for 15 min, virus was pelleted from the supernatant fluid by centrifugation in a Beckman no. 30 rotor, 78,000 x g for 2 h at 4 C. The pellet was suspended in 0.02 M K2H-KH2PO4 buffer (PB) and applied to a DEAEcellulose column (0.9 by 18 cm) after which stepwise elution was performed with increasing concentrations of NaCl in 0.02 M PB. The effluent was assayed for 32P acid-precipitable radioactivity, and plaque assays were performed on each radioactive peak to determine the position of virus eluting from the column (Fig. 1) .
A peak containing 27% of the coxsackievirus a7 applied to the column was eluted in 0.25 M NaCl, whereas only 9% of echovirus 1 was recovered in the -peak eluting in 0.02 M PB. After the conditions of elution were determined, large-scale purification of each virus was achieved by applying 10ll to 10"2 PFU of unlabeled virus to columns (2.5 by 40 cm). Virus eluting from the column was then repelleted in a no. 30 rotor as described above, the pellet was suspended in 0.02 M PB and adjusted to a density of 1.34 g/cm' with CsCl, and ultracentrifugation was carried out at 88,000 x g for 14 For the purification of coxsackieviruses A10, B4, and echovirus 12, DEAE-cellulose chromatography was abandoned because of poor recovery (less than 10%) of infectious virus from the columns. Instead, these viruses were concentrated from cell lysates or from mouse carcasses homogenized in 8.6% sucrose in Tris-phosphate buffer by precipitation with ammonium sulfate as described by Mattern (6) , after which the virus was centrifuged onto a cushion of CsCl (density = 1.40 g/cm3) in an SW25.1 rotor, 60,000 x g, for 2.5 h, at 4 C. The opalescent virus band was collected with a Pasteur pipette and dialyzed free of CsCl as described above. The virus was then layered on a 15 to 30% sucrose gradient in sodium dodecyl sulfate (SDS) buffer (0.5% SDS; 0.1 M NaCl; 0.01 M Tris, pH 7.2; 10-3 M EDTA) in an SW27 rotor and centrifuged at 81,000 x g for 2.5 h at 17 C. Virus was collected by puncturing the bottom of the tube and monitoring optical density at 260 nm in each fraction. Virus-containing fractions were pooled and pelleted in a type 65 rotor, 150,000 x g for 2 h at 20 C. After resuspending the pellets in 0.02 M PB, the solution containing virus was adjusted to a density of 1.34 g/ cm' and centrifuged to equilibrium followed by dialysis as described above.
Preparation of single-stranded viral RNA. The extraction of RNA from purified virions by phenol at room temperature has been previously described (14) .
Preparation of radiolabeled double-stranded RNA. Approximately 1.4 x 10' Vero cells were preincubated for 1 h with phosphate-free Eagle medium containing actinomycin D, 1 Mg/ml. After the fluid was decanted, virus which had previously been dialyzed against phosphate-free medium was added at a multiplicity of 10 to 50 PFU/cell and allowed to adsorb for 30 min at 37 C. The inoculum was then replaced with phosphate-free medium plus actinomycin D, 1 ug/ml. One hour after infection, 3P-orthophosphate was added to a concentration of 100 MCi/ml and the cells were incubated at 37 C for an additional 2 to 4 h. The medium was then decanted, and the cells were harvested. The methods for extraction and purification of viral double-stranded RNA (dsRNA) from infected cells by treatment with hot phenol, differential salt preparation of singlestranded RNA (ssRNA), and chromatography on cellulose columns have been previously described Chromatography of coxsackievirus A7 and echovirus 1 on DEAE-cellulose columns. One milliliter of virus labeled with 32P_orthophosphate and concentrated by ultracentrifugation was applied to a DEAE-cellulose column. Eluent buffer, consisting of 0.02 M K2H-KH2PO4 (PB) and graded increments in NaCI concentration, was added in 40-to 50-ml amounts stepwise and 2-mI fractions were collected. The position of virus eluting from the column was determined by measuring acid-precipitable radioactivit*y (0) in each fraction and then measuring infectivity (0) of each radioactive peak plus selected other fractions. (14) . Purified 
RESULTS
Denaturation in DMSO and determination of optimal concentrations of reactants. For each preparation of radiolabeled dsRNA, the extent of denaturation in DMSO was assessed by measuring conversion to RNase sensitivity under nonannealing conditions. Generally, 6 to 10% of the RNA remained resistant to RNase after DMSO treatment. Since this undenatured dsRNA is presumably unable to participate in annealing reactions, it was treated as "background," and an equal number of counts was subtracted from the result of each annealing reaction after including this control with each set of reactions. In other experiments, each. DMSO-treated dsRNA preparation was allowed to react at 67 C for 2 h; detectable self-annealing (RNase-resistant radioactivity above "background" in the absence of added ssRNA) was not observed. The amount of homologous ssRNA required to achieve complete reannealing of radiolabeled dsRNA was then determined by adding increasing quantities of ssRNA to a constant amount of dsRNA. In nearly all instances, this value was <2 Mg of ssRNA. For a few preparations with low specific activity (2 x 105 counts per min per Mg), 5 to 8 Mg of ssRNA was required to achieve complete homologous reannealing while still having enough radioactive counts in the reaction to determine the fraction annealed for heterologous viral RNA. A representative saturation curve (Fig. 2) With coxsackievirus B4 dsRNA, the fraction hybridized with ssRNA from polioviruses was 0.06 to 0.08, for group A coxsackieviruses 0.10 to 0.14, and for echoviruses 0.16 to 0.33. For multiple RNA combinations (data not shown) of 2 Mg each, the values were 0.17 for poliovirus 1 and echovirus 12, and 0.18 for coxsackievirus A7 and echovirus 12. The nucleotide sequences which these agents hold in common with coxsackievirus B4 therefore appear to be largely overlapping.
In Table 3 , the above data are summarized along with the results of cross-hybridization experiments utilizing 32P-radiolabeled dsRNA of coxsackievirus A7, echovirus 1, and echovirus 12. Relatedness values of 0.31 were obtained for coxsackieviruses A7 and A10, but only 0.11 to 0.15 between either of these agents and the RNA of a group B coxsackievirus or echoviruses, and still lower values, 0.04 to 0.05, with polioviruses. When coxsackievirus B4 dsRNA was used as the source of complementary minus strand, results of 0.10 to 0.14 were obtained with ssRNA of coxsackieviruses of group A, but 0.16 to 0.33 with echovirus RNA. Again, a more distant relationship was observed with poliovirus RNA, 0.06 to 0.08. Echoviruses 1 and 12 RNA appeared to share 0.36 to 0.50 of their sequences reciprocally, while values of 0.23 to 0.38 were obtained with coxsackievirus B4, 0.09 to 0.14 with group A coxsackieviruses, and 0.07 with polioviruses. Additive homologies were not demonstrated when multiple ssRNAs were reacted in combination with each dsRNA. In all instances, ssRNA from MS 2 bacteriophage and uninfected Vero cells resulted in no significant hybridization (<0.01).
Although, in general, less than 30% homology is present among different groups, an apparent exception is the relationship between coxsackievirus B4 and echoviruses, where 16 to 38% homologies were demonstrated reciprocally. Two possible explanations were considered: (i) the virus stocks were cross-contaminated and (ii) a closer relationship exists between these groups than others. To investigate the first possibility, serial dilutions of concentrated virus stocks of coxsackievirus B4 and echoviruses 1 and 12 were neutralized by the plaque-reduction method (14) in the presence of a constant amount (1:10 dilution) of each antiserum. In all instances, the log neutralization indices were >3.75, indicating that any hypothetical contaminant constituted less than 1/9,000 of the population of PFU. Five surviving plaques for each virus stock were cloned three times and then passaged one additional time in Vero cells. Neutralization titers of these clones, when tested with homologous antiserum, were identical to those of the uncloned virus population, indicating that even minor cross-contamination among coxsackievirus B4 and echoviruses 1 and 12 had not occurred. To examine the second possibility, that these viruses were indeed closely related, cross-neutralization tests were performed. No relationship was demonstrated (Table 4 ). It appears, therefore, that a closer relationship exists between the nucleotide sequences of coxsackievirus B4 and echoviruses than with group A coxsackieviruses, but that this relationship is not reflected by shared neutralizing antibodies.
To determine whether some of the nucleotide sequences apparently shared by enteroviruses might merely be due to polyadenylate present at the 3'-terminus of each virion RNA (13) rather than indicating true genetic relatedness, 32P-labeled dsRNA from poliovirus 1 was annealed with saturating quantitites of either homologous ssRNA or polyadenylate ( Table 5) . The results show that polyadenylate alone accounts for a relatedness value of only 0.009.
DISCUSSION
Cross-hybridization of the RNA of human enteroviruses supports the essential qualitative validity of the biological classification into polioviruses, group A and B coxsackieviruses, and echoviruses. At least for the strains included in the present study and under the reaction conditions used, the generalization can be made that approximately 0.3 to 0.5 of the genome is shared by different serotypes within the same group, for example, coxsackieviruses of group A with each other and echoviruses with each other. With poliovirus 1, previous results (14) Despite remarkable biochemical, biophysical, morphologic, and biological properties shared by human enteroviruses, their nucleotide sequences are very dissimilar. It is nevertheless possible that their proteins are more closely related than the present data would imply due to degeneracy in the genetic code. Thus, comparisons of the genes for rabbit and duck hemoglobins by DNA-RNA hybridization indicate that only 5 to 10% of the nucleotide sequences are shared by these species (10), yet protein sequencing of rabbit and avian globins shows that approximately 70% of the amino acid sequences are the same (2) . Direct comparisons of the proteins of human enteroviruses are needed to resolve whether these proteins exhibit greater homologies than the nucleotide sequences coding for them.
